
Reset all filters
01 2GlaxoSmithKline Inc.
02 1Blank
Reset all filters
01 11308102
02 12103707
03 12103708
Reset all filters
01 2Topotecan Hydrochloride
02 1Blank
Reset all filters
01 2Sterile lyophilized Powder in single dose vials
02 1Blank
Reset all filters
01 12009-09-29
02 22012-02-07
Patent Expiration Date : 2012-02-07
Date Granted : 2003-12-09
Brand Name : HYCAMTIN
Patent Number : 2103707
Filing Date : 1992-02-07
Strength per Unit : 4mg as free base per vial
Dosage Form : Sterile lyophilized Powder in single dose vials
Human Or VET : Human
Route of Administration : Intravenous Administration
Patent Expiration Date : 2012-02-07
Date Granted : 2003-12-09
Patent Expiration Date : 2012-02-07
Date Granted : 2004-04-27
Brand Name : HYCAMTIN
Patent Number : 2103708
Filing Date : 1992-02-07
Strength per Unit : 4mg as free base per vial
Dosage Form : Sterile lyophilized Powder in single dose vials
Human Or VET : Human
Route of Administration : Intravenous Administration
Patent Expiration Date : 2012-02-07
Date Granted : 2004-04-27
Patent Expiration Date : 2009-09-29
Date Granted :
Brand Name :
Patent Number : 1308102
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2009-09-29
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF